PULMONARY ARTERIOPATHY

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting PULMONARY ARTERIOPATHY:

# Drug Count
0 CARBOPLATIN 16
1 METHOTREXATE SODIUM 16
2 THIOTEPA 16
3 ETOPOSIDE 15
4 METHOTREXATE 15
5 CISPLATIN 14
6 CYCLOPHOSPHAMIDE 13
7 CYCLOPHOSPHAMIDE FOR INJECTION 13
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 13
9 VINCRISTINE SULFATE 10
See all common drugs associated with PULMONARY ARTERIOPATHY

PULMONARY ARTERIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 THIOTEPA 16 0.0016
1 DIAZOXIDE 1 0.0014
2 DEFEROXAMINE MESYLATE 1 0.0005
3 NITRIC OXIDE 2 0.0004
4 VINCRISTINE SULFATE 10 0.0003
5 ENFORTUMAB VEDOTIN 2 0.0003
6 ETOPOSIDE 15 0.0002
7 CISPLATIN 14 0.0002
8 ACLIDINIUM BROMIDE 1 0.0002
9 AZTREONAM 1 0.0001
See all drugs enriched for association with PULMONARY ARTERIOPATHY

PULMONARY ARTERIOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Topoisomerase Inhibitor [EPC] 15 0.0002
2 Vitamin K [EPC] 1 0.0001
3 Anti-anginal [EPC] 1 0.0001
4 Barbiturate [EPC] 1 0.0001
5 Antisense Oligonucleotide [EPC] 1 0.0001
6 Alkylating Drug [EPC] 17 0.0001
7 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
8 Platinum-based Drug [EPC] 17 0.0001
9 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
See all drug classes enriched for association with PULMONARY ARTERIOPATHY